Cochrane Abstracts
Oral non‐steroidal anti‐inflammatory drug therapy for lung disease in cystic fibrosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oral Non‐steroidal Anti‐inflammatory Drug Therapy for Lung Disease in Cystic Fibrosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433509/all/Oral_non‐steroidal_anti‐inflammatory_drug_therapy_for_lung_disease_in_cystic_fibrosis.
Oral non‐steroidal anti‐inflammatory drug therapy for lung disease in cystic fibrosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433509/all/Oral_non‐steroidal_anti‐inflammatory_drug_therapy_for_lung_disease_in_cystic_fibrosis. Accessed January 15, 2025.
Oral non‐steroidal anti‐inflammatory drug therapy for lung disease in cystic fibrosis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433509/all/Oral_non‐steroidal_anti‐inflammatory_drug_therapy_for_lung_disease_in_cystic_fibrosis
Oral Non‐steroidal Anti‐inflammatory Drug Therapy for Lung Disease in Cystic Fibrosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433509/all/Oral_non‐steroidal_anti‐inflammatory_drug_therapy_for_lung_disease_in_cystic_fibrosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oral non‐steroidal anti‐inflammatory drug therapy for lung disease in cystic fibrosis
ID - 433509
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433509/all/Oral_non‐steroidal_anti‐inflammatory_drug_therapy_for_lung_disease_in_cystic_fibrosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
